Role of Clinical Genetic Testing in the Management of Aortopathies
- PMID: 33475873
- DOI: 10.1007/s11886-020-01435-6
Role of Clinical Genetic Testing in the Management of Aortopathies
Abstract
Purpose of review: Thoracic aortic aneurysms (TAA) have a strong heritable basis, and identification of a genetic etiology has important implications for patients with TAA and their relatives. This review provides an overview of Mendelian causes of TAA, discusses important considerations for genetic testing, and summarizes the impact a genetic diagnosis may have on a patient's medical care.
Recent findings: Thoracic aortic disease may be non-syndromic or seen as part of a genetic syndrome, such as Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome. Expanded access to genetic testing has revealed the wide and overlapping phenotypic spectrum of these conditions, highlighting the need for genetic testing to establish an accurate diagnosis. Important aspects of genetic evaluation include thorough phenotyping through family history and physical examination, selection of an appropriate genetic test driven by the patient's phenotype, and careful interpretation of genetic test results. Improved understanding of the natural history of these conditions has led to tailored management recommendations, including gene-based recommendations for prophylactic surgical repair. Identification of a genetic etiology allows for careful monitoring of disease progression, informs the timing of prophylactic surgical repair, and facilitates the identification of other at-risk relatives through cascade genetic testing.
Keywords: Aortopathy; Genetic counseling; Genetic testing; Marfan syndrome.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Ito S, Akutsu K, Tamori Y, Sakamoto S, Yoshimuta T, Hashimoto H, et al. Differences in atherosclerotic profiles between patients with thoracic and abdominal aortic aneurysms. Am J Cardiol. 2008;101(5):696–9. https://doi.org/10.1016/j.amjcard.2007.10.039 . - DOI - PubMed
-
- Hemminki K, Li X, Johansson SE, Sundquist K, Sundquist J. Familial risks of aortic aneurysms among siblings in a nationwide Swedish study. Genet Med. 2006;8(1):43–9. https://doi.org/10.1097/01.gim.0000195973.60136.48 . - DOI - PubMed
-
- Rigelsky CM, Moran RT. Genetics of syndromic and nonsyndromic aortopathies. Curr Opin Pediatr. 2019;31(6):694–701. https://doi.org/10.1097/MOP.0000000000000836 . - DOI - PubMed
-
- Tiecke F, Katzke S, Booms P, Robinson PN, Neumann L, Godfrey M, et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet. 2001;9(1):13–21. https://doi.org/10.1038/sj.ejhg.5200582 . - DOI - PubMed
-
- Takeda N, Inuzuka R, Maemura S, Morita H, Nawata K, Fujita D, et al. Impact of pathogenic FBN1 variant types on the progression of aortic disease in patients with Marfan syndrome. Circ Genomic Precis Med. 2018;11(6):e002058. https://doi.org/10.1161/CIRCGEN.117.002058 . - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
